YLYigal Leykin

Yigal Leykin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yigal Leykin has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 February 2016
      • Vol. 107  (1) , 1-13

    Activity-based costing analysis of the analgesic treatments used in postoperative pain management in Italy.

    by Andrea Fanelli, Matteo Ruggeri, Michele Basile, Americo Cicchetti, Flaminia Coluzzi, Giorgio Della Rocca, Pierangelo Di Marco, Clelia Esposito, Guido Fanelli, Paolo Grossi, et al.

    The aim of this analysis is to evaluate the costs of 72-hour postoperative pain treatment in patients undergoing major abdominal, orthopedic and thoracic procedures in nine different Italian hospitals, defined as the cumulative cost of drugs, consumable materials and time required for anesthesiologists, surgeons and nurses to administer each analgesic technique. Nine Italian hospitals have been involved in this study through the administration of a questionnaire aimed to acquire information about the Italian clinical practice in terms of analgesia. This study uses activity-based costing (ABC) analysis to identify, measure and give value to the resources required to provide the therapeutic treatment used in Italy to manage the postoperative pain patients face after surgery. A deterministic sensitivity analysis (DSA) has been performed to identify the cost determinants mainly affecting the final cost of each treatment analyzed. Costs have been reclassified according to three surgical macro-areas (abdominal, orthopedic and thoracic) with the aim to recognize the cost associated not only to the analgesic technique adopted but also to the type of surgery the patient faced before undergoing the analgesic pathway. Fifteen different analgesic techniques have been identified for the treatment of moderate to severe pain in patients who underwent a major abdominal, orthopedic or thoracic surgery. The cheapest treatment actually employed is the oral administration "around the clock" (€ 8.23), whilst the most expensive is continuous peripheral nerve block (€ 223.46). The intravenous patient-controlled analgesia costs € 277.63. In terms of resources absorbed, the non-continuous administration via bolus is the gold standard in terms of cost-related to the drugs used (€ 1.28), and when administered pro re nata it also absorbs the lowest amount of consumables (€0.58€) compared to all other therapies requiring a delivery device. The oral analgesic administration pro re nata is associated to the lowest cost in terms of health professionals involved (€ 6.25), whilst intravenous PCA is the most expensive one (€ 245.66), requiring a massive monitoring on the part of physicians and nurses. The analysis successfully collected information about costs of 72-hour postoperative pain treatment in patients undergoing major abdominal, orthopedic and thoracic procedures in all the nine different Italian hospitals. The interview showed high heterogeneity in the treatment of moderate to severe pain after major abdominal, orthopedic and thoracic surgeries among responding anesthesiologists, with 15 different analgesic modalities reported. The majority of the analgesic techniques considered in the analysis is not recommended by any guideline and their application in real life can be one of the reasons for the high incidence of uncontrolled pain, which is still reported in the postoperative period. Health care costs have become more and more important, although the choice of the best analgesic treatment should be a compromise between efficacy and economic considerations.


  • Endotracheal kinking of a double-lumen tube

    by Claudia Ambrosio, Yigal Leykin, Tommaso Pellis, Jay B. Brodsky


  • Anesthesia and Postoperative Analgesia After Intra‐articular Injection of Warmed Versus Room‐Temperature Levobupivacaine: A Double‐Blind Randomized Trial

    by Yigal Leykin, Rachele Nespolo, Francesca Foltran, Lorenzo Burato, Nadia Noal, Marco Baciarello, Guido Fanelli

    Purpose: This prospective, randomized, blinded study was designed to compare the effects of warmed versus room‐temperature levobupivacaine in patients undergoing knee arthroscopy and partial meniscectomy. Methods: Patients were randomly allocated into 2 groups of 16 patients each. In all patients the 2 portal sites were infiltrated with 10 mL of room‐temperature mepivacaine (20 mg/mL). In the first group, patients underwent intra‐articular injection of 20 mL of levobupivacaine (5 mg/mL) and 0.005‐mg/mL epinephrine (1:200,000) at a temperature of 40°C ± 0.2°C, whereas in the second group the levobupivacaine and epinephrine were at room temperature (25°C ± 0.5°C). Pain was graded and recorded intraoperatively and postoperatively by use of a visual analog scale (VAS). Analgesia was supplemented if the VAS score was 4 cm or greater with morphine intraoperatively or ketorolac postoperatively. Results: There were no significant differences between groups in intraoperative and postoperative VAS values. There was no need for morphine as a rescue dose in any patient during surgery. Eight patients treated with warmed levobupivacaine and seven patients treated with room‐temperature levobupivacaine requested a single rescue dose of ketorolac (30 mg) postoperatively. Conclusions: No compelling evidence exists to suggest that intra‐articular injection of warmed levobupivacaine is more effective than room‐temperature levobupivacaine for intraoperative anesthesia and postoperative analgesia in patients undergoing partial meniscectomy during knee arthroscopy. Level of Evidence: Level I, randomized controlled trial.


    • 1 September 2008
      • Vol. 74  (9) , 475-9

    A prospective, randomized, double-blind comparison between parecoxib and ketorolac for early postoperative analgesia following nasal surgery.

    by Y Leykin, A Casati, A Rapotec, M Dal Sasso, L Barzan, G Fanelli, T Pellis

    The aim of this prospective, randomized, double-blind study was to compare the efficacy of parecoxibfor postoperative analgesia after endoscopic turbinate and sinus surgery, with the non-selective non-steroid anti-inflammatory drug (NSAID), ketorolac. A total of 50 patients with an ASA physical status I-II, receiving functional endoscopic sinus surgery (FESS) and endoscopic turbinectomy after local infiltration with 1% mepivacaine, were randomly assigned to receive intravenous administration of either 40 mg parecoxib (N.=25) or 30 mg ketorolac (N.=25), 15 min before the discontinuation of anaesthesia and then every 8 h postoperatively. A blinded observer recorded the incidence and severity of pain upon admission to the postanesthesia care unit (PACU), as well as 10, 20, and 30 min after PACU admission. Thereafter, observations continued every 1 h for the first 6 h, and then 12 h and 24 h after surgery. The area under the curve of the visual analogue scale (AUCVAS) calculated during the study period was 635 (26-1 413) in the Parecoxib group and 669 (28-1 901) in the Ketorolac group (P=0.54). Rescue morphine analgesia was required by 12 patients (48%) in the Parecoxib group and 11 patients (44%) in the Ketorolac group (P<0.05); while mean morphine consumption was 5 +/- 2.5 mg and 5 +/- 2.0 mg in Ketorolac and Parecoxib groups, respectively (P<0.05). No differences in the incidence of side effects were recorded between the two groups. Patient satisfaction was similarly high in both groups, and all patients were discharged uneventfully 24 h after surgery. In patients undergoing endoscopic nasal surgery and local infiltration with 1% mepivacaine, parecoxib administered before discontinuing general anesthesia is as effective in treating early postoperative pain as ketorolac.


  • Perioperative management of 195 consecutive bariatric patients

    by Y. Leykin, T. Pellis, E. Del Mestro, G. Fanti, B. Marzano


  • Open Access

    Comparison of Parecoxib and Proparacetamol in Endoscopic Nasal Surgery Patients

    by Yigal Leykin, Andrea Casati, Alessandro Rapotec, Massimiliano Dalsasso, Luigi Barzan, Guido Fanelli, Tommaso Pellis

    Leykin Y, et al. Yonsei Med J. 2008 Jun;49(3):383-388. http://dx.doi.org/10.3349/ymj.2008.49.3.383